COVID-19 vaccination for patients with epilepsy: A Chinese expert consensus

Xuewu Liu,Qun Wang,Liankun Ren,Xiqin Fang,Zhiyi He,Jing Ding,Kang Wang,Huiqin Xu,Hua Zhang,Yijun Song,Qiang Lu,Meizhen Sun,Xiong Han,Lili Cao,Weihong Lin,Xiaoyi Li,Qing Zhang,Yao Ding,Furong Wang,Tiancheng Wang,Jiwen Wang,Xiaorong Liu,Yuan Wu,Yangmei Chen,Zhanhui Feng,Shoulei Wang,Xiangqing Wang,Yuguang Guan,Xufang Xie,Huapin Huang,Ming Zhang,Xiaoshan Wang,Zhen Hong,Wen Jiang,Yanbing Han,Yulei Deng,Jiangming Zhao,Jianxiang Liao,Yu Wang,Yajun Lian
DOI: https://doi.org/10.1016/j.yebeh.2023.109387
IF: 3.337
2023-10-01
Epilepsy & Behavior
Abstract:Coronavirus disease-2019 (COVID-19) first emerged in late 2019 and has since spread worldwide. More than 600 million people have been diagnosed with COVID-19, and over 6 million have died. Vaccination against COVID-19 is one of the best ways to protect humans. Epilepsy is a common disease, and there are approximately 10 million patients with epilepsy (PWE) in China. However, China has listed "uncontrolled epilepsy" as a contraindication for COVID-19 vaccination, which makes many PWE reluctant to get COVID-19 vaccination, greatly affecting the health of these patients in the COVID-19 epidemic. However, recent clinical practice has shown that although a small percentage of PWE may experience an increased frequency of seizures after COVID-19 vaccination, the benefits of COVID-19 vaccination for PWE far outweigh the risks, suggesting that COVID-19 vaccination is safe and recommended for PWE. Nonetheless, vaccination strategies vary for different PWE, and this consensus provides specific recommendations for PWE to be vaccinated against COVID-19.
psychiatry,clinical neurology,behavioral sciences
What problem does this paper attempt to address?